ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity

被引:75
作者
Whittles, CE
Pocock, TM
Wedge, SR
Kendrew, J
Hennequin, LF
Harper, SJ
Bates, DO
机构
[1] Univ Bristol, Preclin Vet Sch, Microvasc Res Labs, Dept Physiol, Bristol, Avon, England
[2] Astra Zeneca, Canc & Infect Res, Macclesfield, Cheshire, England
[3] Univ Bristol, Southmead Hosp, Acad Renal Labs, Bristol, Avon, England
关键词
VEGF; flk-1/KDR; flt-1; vascular permeability; HUVEC; endothelial cells; angiogenesis;
D O I
10.1038/sj.mn.7800164
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Vascular endothelial growth factor (VEGF) increases vascular permeability and angiogenesis in many pathological conditions including cancer, arthritis, and diabetes, VEGF activates VEGF-Receptor 1(VEGF-R1) and VEGF-Receptor 2 (VEGF-R2), which autophosphorylate to initiate a signaling cascade resulting in angiogenesis and increased microvascular permeability. Here we describe a novel VEGF-R2 selective inhibitor. ZM323881 (5-{[7-(benzyloxy) quinazolin-+-yl]amino-+-fluor-2-methylphenol), that is a potent and selective inhibitor of VEGF-R2 tyrosine kinase in vitro (IC50 < 2 nM), compared with other receptor tyrosine kinases, including VEGF-R1 (IC50 > 50 muM). Methods: Endothelial cell proliferation was assayed by H-3-thymidine incorporation in response to VEGF-A +/- ZM323881. The effect of ZM323881 on VEGF-mediated permeability was measured in frog microvessels using the Landis Michel technique. To ensure that ZM323881 was effective in frogs, western analysis was performed on protein extracted from frog lungs incubated in the presence or absence of VEGF-A or VEGF-A with ZN323881. Results: ZM323881 inhibits VEGF-A-induced endothelial cell proliferation (IC50 = 8 nM) and VEGF-R2 tyrosine phosphorylation in vitro. VEGF-A-mediated increases in vascular permeability in perfused mesenteric microvessels in vivo were reversibly abolished by both ZM323881 and the class III receptor tyrosine kinase inhibitor PTK787/ZK222584. Conclusions: These data suggest that VEGF-R2 phosphorylation is necessary for VEGF-A-mediated increases in microvascular permeability in vivo.
引用
收藏
页码:513 / 522
页数:10
相关论文
共 35 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]  
BASSER R, 2001, P 37 ANN M AM SOC CL
[3]   Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels [J].
Bates, DO ;
Curry, FE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (06) :H2520-H2528
[4]   Vascular endothelial growth factor and microvascular permeability [J].
Bates, DO ;
Lodwick, D ;
Williams, B .
MICROCIRCULATION, 1999, 6 (02) :83-96
[5]  
Curry FE, 1983, CARDIOVASCULAR PHY P, P1
[6]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[7]  
Drevs J, 2000, CANCER RES, V60, P4819
[8]   VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) AND VEGF RECEPTOR-2 (FLK-1) ARE EXPRESSED DURING VASCULOGENESIS AND VASCULAR DIFFERENTIATION IN THE QUAIL EMBRYO [J].
FLAMME, I ;
BREIER, G ;
RISAU, W .
DEVELOPMENTAL BIOLOGY, 1995, 169 (02) :699-712
[9]   Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer [J].
Gordon, MS ;
Margolin, K ;
Talpaz, M ;
Sledge, GW ;
Holmgren, E ;
Benjamin, R ;
Stalter, S ;
Shak, S ;
Adelman, DC .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :843-850
[10]   VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR PROMOTES TYROSINE PHOSPHORYLATION OF MEDIATORS OF SIGNAL-TRANSDUCTION THAT CONTAIN SH2 DOMAINS - ASSOCIATION WITH ENDOTHELIAL-CELL PROLIFERATION [J].
GUO, DQ ;
JIA, Q ;
SONG, HY ;
WARREN, RS ;
DONNER, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6729-6733